CareDx, Inc
CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions. Our understanding of transplant patients and care teams allows us to develop solutions to extend graft life. With two decades of commitment to transplant care, we have developed close partnerships across the transplant ecosystem that grow stronger every day. In 2019, acquired Ottr and XynManagement to expand portfolio into software and services supporting transplant centers. Our latest area of innovation, we are leveraging our core technologies to help biopharma companies accelerate clinical development.
Company details
Find locations served, office locations
- Business Type:
- Software vendor
- Industry Type:
- Clinical Services
- Market Focus:
- Globally (various continents)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About us
CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions.
TESTING SERVICES
- Launched first commercial product, AlloMap® Heart, in 2005, now used by over 90% of U.S. transplant centers
- Launched second surveillance product, AlloSure®, in 2017, using dd-cfDNA to determine graft injury
- Ushering in the next generation in transplant management by leading the shift to multi-modality testing with HeartCare®, KidneyCareTM, HistoMap, and UroMap
Through a series of acquisitions in the 2010s, built portfolio of HLA typing solutions for matching donor organs with recipients
Our Mission
We are committed to improving transplant patient outcomes by providing innovative and intelligent solutions throughout the entire patient journey.